CN102781415A - 2,3-二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途 - Google Patents

2,3-二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途 Download PDF

Info

Publication number
CN102781415A
CN102781415A CN2010800570221A CN201080057022A CN102781415A CN 102781415 A CN102781415 A CN 102781415A CN 2010800570221 A CN2010800570221 A CN 2010800570221A CN 201080057022 A CN201080057022 A CN 201080057022A CN 102781415 A CN102781415 A CN 102781415A
Authority
CN
China
Prior art keywords
seborrheic dermatitis
dermatitis
composition
dihydroxypropyl
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800570221A
Other languages
English (en)
Chinese (zh)
Inventor
C·德舍莱特
D·勒杜莱斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Priority to CN201610511468.6A priority Critical patent/CN106063768A/zh
Publication of CN102781415A publication Critical patent/CN102781415A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN2010800570221A 2009-12-18 2010-12-17 2,3-二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途 Pending CN102781415A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610511468.6A CN106063768A (zh) 2009-12-18 2010-12-17 2,3‑二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0959165 2009-12-18
FR0959165A FR2954124B1 (fr) 2009-12-18 2009-12-18 Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
PCT/EP2010/070028 WO2011073370A2 (fr) 2009-12-18 2010-12-17 Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201610511468.6A Division CN106063768A (zh) 2009-12-18 2010-12-17 2,3‑二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途

Publications (1)

Publication Number Publication Date
CN102781415A true CN102781415A (zh) 2012-11-14

Family

ID=42358115

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2010800570221A Pending CN102781415A (zh) 2009-12-18 2010-12-17 2,3-二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途
CN201610511468.6A Pending CN106063768A (zh) 2009-12-18 2010-12-17 2,3‑二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201610511468.6A Pending CN106063768A (zh) 2009-12-18 2010-12-17 2,3‑二羟基丙基十二烷酸酯用于治疗脂溢性皮炎的用途

Country Status (21)

Country Link
US (1) US9101785B2 (https=)
EP (1) EP2512420B1 (https=)
JP (1) JP6129557B2 (https=)
KR (1) KR101774608B1 (https=)
CN (2) CN102781415A (https=)
AU (1) AU2010332759B2 (https=)
BR (1) BR112012014658A2 (https=)
CA (1) CA2784542C (https=)
ES (1) ES2757816T3 (https=)
FR (1) FR2954124B1 (https=)
GE (1) GEP20146170B (https=)
IL (1) IL220423A (https=)
MA (1) MA33842B1 (https=)
MX (1) MX338441B (https=)
NZ (1) NZ601279A (https=)
PT (1) PT2512420T (https=)
RU (1) RU2568833C2 (https=)
TN (1) TN2012000301A1 (https=)
UA (1) UA110332C2 (https=)
WO (1) WO2011073370A2 (https=)
ZA (1) ZA201204287B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120016980A (ko) 2010-08-17 2012-02-27 한국전자통신연구원 영상 부호화 방법 및 장치, 그리고 복호화 방법 및 장치
FR2983858B1 (fr) 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
FR2992859B1 (fr) 2012-07-09 2014-10-03 Fabre Pierre Dermo Cosmetique Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes
EP3160427B1 (en) * 2014-06-24 2017-09-13 Unilever N.V. Hair treatment composition
WO2018125694A1 (en) * 2017-01-01 2018-07-05 Khalifa University of Science and Technology Compositions from halophyte plants and methods of use thereof
IT201800002843A1 (it) 2018-02-20 2019-08-20 Idi Farm S R L Composizione per l’uso nel trattamento della dermatite seborroica
KR20230132799A (ko) * 2021-01-29 2023-09-18 삐에르화브르데르모-코스메띠끄 여드름 민감성 피부의 일상 관리에 유용한 국소 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921694A (en) * 1987-06-24 1990-05-01 Beiersdorf Aktiengesellschaft Deodorizing and antimicrobial composition for use in cosmetic or topical formulations
US6110908A (en) * 1995-03-31 2000-08-29 Guthery; B. Eugene Fast acting and persistent topical antiseptic
US6174892B1 (en) * 1993-10-15 2001-01-16 Merck & Co., Inc. Method of treating acne with 5-α reductase inhibitors
FR2867973A1 (fr) * 2004-03-26 2005-09-30 B Prince Sarl Lab Composition de soin capillaire contenant du sabal
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057501A (en) * 1990-03-13 1991-10-15 Dermatologic Research Corporation Methods for treatment of papulosquamous and eczematous diseases
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
FR2731615B1 (fr) * 1995-03-15 1997-07-25 Fabre Pierre Dermo Cosmetique Compositions ecran-solaire comprenant un melange de particules d'oxyde de titane et/ou de zinc, leur procede de preparation et leur utilisation
US6696484B2 (en) * 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
ITMI20011732A1 (it) * 2001-08-07 2003-02-07 Indena Spa Composizioni farmaceutiche e/o cosmetiche orali per il trattamento e la prevenzione di disturbi del cuoio capelluto
ITBS20010111A1 (it) * 2001-12-20 2003-06-20 Paoli Ambrosi Gianfranco De Composizione per uso topico a base dell'estere etilico dell'acido linoleico e e del trietil estere dell'acido citrico associati con opportun
KR100564386B1 (ko) * 2002-05-13 2006-03-27 주식회사 마이코플러스 4-하이드록시-5-메톡시-4-[2-메틸-3-(3-메틸-2-부테닐)-2-옥시란닐]-1-옥사스피로[2,5]옥탄-6-온을 함유한 지루치료용 약제학적 조성물
JP2005040403A (ja) * 2003-07-23 2005-02-17 Shiseido Co Ltd 敏感肌のための美容施術方法
WO2005079164A2 (ja) * 2004-02-10 2005-09-01 Kyushu Tlo Co Ltd ５α−リダクターゼ阻害剤
US20090054522A1 (en) * 2005-02-22 2009-02-26 Maruzen Pharmaceuticals Co., Ltd. Hair Care Product

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921694A (en) * 1987-06-24 1990-05-01 Beiersdorf Aktiengesellschaft Deodorizing and antimicrobial composition for use in cosmetic or topical formulations
US6174892B1 (en) * 1993-10-15 2001-01-16 Merck & Co., Inc. Method of treating acne with 5-α reductase inhibitors
US6110908A (en) * 1995-03-31 2000-08-29 Guthery; B. Eugene Fast acting and persistent topical antiseptic
FR2867973A1 (fr) * 2004-03-26 2005-09-30 B Prince Sarl Lab Composition de soin capillaire contenant du sabal
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
H-J. NIEDERPRÜM等: ""Inhibition of Steroid 5α-Reductase Activity by Aliphatic Fatty Acids"", 《ANNALS OF THE NEW YORK ACADEMY OF SCIENCES》 *

Also Published As

Publication number Publication date
ZA201204287B (en) 2013-05-29
KR20120094501A (ko) 2012-08-24
EP2512420A2 (fr) 2012-10-24
CA2784542C (fr) 2018-07-17
EP2512420B1 (fr) 2019-09-04
JP6129557B2 (ja) 2017-05-17
FR2954124A1 (fr) 2011-06-24
CN106063768A (zh) 2016-11-02
JP2013514328A (ja) 2013-04-25
MX338441B (es) 2016-04-14
US9101785B2 (en) 2015-08-11
KR101774608B1 (ko) 2017-09-04
WO2011073370A3 (fr) 2012-07-19
WO2011073370A2 (fr) 2011-06-23
CA2784542A1 (fr) 2011-06-23
AU2010332759B2 (en) 2015-04-16
RU2012128541A (ru) 2014-01-27
UA110332C2 (en) 2015-12-25
GEP20146170B (en) 2014-09-25
FR2954124B1 (fr) 2012-04-06
AU2010332759A1 (en) 2012-08-09
RU2568833C2 (ru) 2015-11-20
ES2757816T3 (es) 2020-04-30
US20120258065A1 (en) 2012-10-11
IL220423A (en) 2016-04-21
NZ601279A (en) 2015-02-27
TN2012000301A1 (fr) 2013-12-12
MA33842B1 (fr) 2012-12-03
MX2012007142A (es) 2012-07-03
PT2512420T (pt) 2019-12-13
BR112012014658A2 (pt) 2016-04-05

Similar Documents

Publication Publication Date Title
DK166801B1 (da) Anvendelse af en inhibitor og praeparat til haarvaekstmodifikation
CA2132369C (en) Use for the treatment of mixed skins, of an effective quantity of active substances
JP2000226317A (ja) 毛髪保護作用と毛髪減損の予防性並びにアンドロゲン性脱毛症の外因作用とその結果もたらされる毛髪減損の低下性において、改善された性質を有するヘアロ―ション
AU2010332759B2 (en) Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhoea
US3729560A (en) Treatment of hair and scalp with compositions containing estriol
CA2780267A1 (en) Compositions and methods for stimulating hair growth
CN100558340C (zh) 葫芦科油用于抑制5α-还原酶活性的应用
JP2000503628A (ja) サブスタンスｐアンタゴニストとしての少なくとも１つのベータ−アドレナリンアゴニストの使用
JP5069841B2 (ja) 米糠から得られる植物ステロールエステルおよびトリテルペンアルコールエステルの使用方法
US5869063A (en) Dermatological and cosmetic compositions containing marama bean extract
US20160136071A1 (en) Topical bimatoprost for promoting hair growth containing formulations
US6379684B1 (en) Cosmetic compositions containing cromolyn compounds for revitalizing the skin
CN101596152A (zh) 含羟基积雪草苷和/或特米诺苷和精氨酸和/或其盐和/或其衍生物的组合的组合物及用途
CN100469348C (zh) 化妆品或皮肤病学组合物
JPH0262526B2 (https=)
JP5714694B2 (ja) ジヒドロデヒドロジイソオイゲノールの使用およびジヒドロデヒドロジイソオイゲノールを含む製剤
US9126056B2 (en) Method of promoting hair growth
HK1178443A (en) Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhea
JP2018516921A (ja) 脱毛症治療のための化粧品用または皮膚病用組成物
JP2001163762A (ja) スリミング剤
US20240398694A1 (en) Skincare composition containing shatavari extract
KR102817922B1 (ko) 피부장벽 강화용 조성물
JP3744757B2 (ja) 化粧料
EP2465581B1 (en) Non-therapeutic use of a composition for promoting hair growth
CN118450885A (zh) 用于护理皮肤的组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1178443

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121114